| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/28/2004 | EP1411998A1 Stents with vitronectin receptor antagonists against restenosis |
| 04/28/2004 | EP1411984A2 Combination medicament for treatment of neoplastic diseases which contains cyanoguanidine ikk inhibitors and a second anti-neoplastic drug |
| 04/28/2004 | EP1411983A1 Bispecific antibodies that bind to vegf receptors |
| 04/28/2004 | EP1411970A2 Use of sarp-1 for the treatment and/or prevention of scleroderma |
| 04/28/2004 | EP1411968A2 Glp-1 exendin-4 peptide analogs and uses thereof |
| 04/28/2004 | EP1411966A2 Method for treating secondary tissue degeneration associated with central nervous system injury |
| 04/28/2004 | EP1411960A1 Fortified rice bran food product and method for promoting cardiovascular health |
| 04/28/2004 | EP1411952A1 Use of at least one glycoinhibitor substance |
| 04/28/2004 | EP1411948A1 Tetrahydroquinoxalines acting as bradykinin antagonists |
| 04/28/2004 | EP1411947A2 Salts of substituted 1, 2, 3, 4-tetrahydroisoquinoline-2-carboxylic acid derivatives |
| 04/28/2004 | EP1411943A2 Methods for treatment of cognitive and menopausal disorders with d-threo methylphenidate |
| 04/28/2004 | EP1411935A1 Use of 4- (4-thiazolyl)phenoxl] alkoxy-benzamidine derivatives for treatment of osteoporosis |
| 04/28/2004 | EP1411932A1 Substituted oxazolidinones for combinational therapy |
| 04/28/2004 | EP1411929A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 04/28/2004 | EP1411924A1 Hypertension treatment |
| 04/28/2004 | EP1411923A1 Pharmaceutical compositions of amlodipine and atorvastatin |
| 04/28/2004 | EP1411919A1 (-)-olivil as antioxidant |
| 04/28/2004 | EP1411915A2 Nitrate ester-cyclodextrin complexes for treating diseases, particularly coronary diseases |
| 04/28/2004 | EP1411910A1 (+)-cycloolivil as antioxidant obtained from stereospermum personatum |
| 04/28/2004 | EP1411909A1 Pharmaceutical composition comprising (-)-secoisolariciresinol |
| 04/28/2004 | EP1411901A1 Gastric retention controlled drug delivery system |
| 04/28/2004 | EP1411898A1 Pharmaceutical composition comprising lipids with a polar and a nonpolar moiety |
| 04/28/2004 | EP1411895A2 Oral pharmaceutical composition comprising an active principle capable of being subjected to high effect during its first passage through the intestine |
| 04/28/2004 | EP1411881A2 5HT sb 2C /sb RECEPTOR MODULATORS |
| 04/28/2004 | EP1263718B1 Novel use of phenylheteroalkylamine derivatives |
| 04/28/2004 | EP1263715B1 Novel phenylheteroalkylamine derivatives |
| 04/28/2004 | EP1255559B1 Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease (cad) for treating cardiac disease |
| 04/28/2004 | EP1244642B1 Substituted oxazoles and thiazoles derivatives as hppar alpha activators |
| 04/28/2004 | EP1227098B1 Triazolopurine derivatives, drug compositions containing the same and adenosine a3 receptor affinitive agents |
| 04/28/2004 | EP1208096B1 Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity |
| 04/28/2004 | EP1206448B1 Novel vitamin d analogues |
| 04/28/2004 | EP1162981B1 Dexrazoxane for the treatment of accidental extravasation of anthracyclines |
| 04/28/2004 | EP1154983B1 Novel substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines |
| 04/28/2004 | EP1137631B1 REVERSIBLE AQUEOUS pH SENSITIVE LIPIDIZING REAGENTS, COMPOSITIONS AND METHODS OF USE |
| 04/28/2004 | EP1107737B1 Microparticles for use in needleless injection |
| 04/28/2004 | EP1051394B1 Potassium channel inhibitors |
| 04/28/2004 | EP0885309B1 Direct molecular diagnosis of friedreich ataxia |
| 04/28/2004 | EP0809515B1 Therapeutic inhibitor of vascular smooth muscle cells |
| 04/28/2004 | EP0782857B1 use of 4-acylaminopyridine derivatives in the manufacture of a medicament for treating cerebrovascular disorders |
| 04/28/2004 | EP0730469B1 Modified truncated complement system regulators |
| 04/28/2004 | EP0585366B1 Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood |
| 04/28/2004 | EP0558648B1 Improved matrix metalloprotease inhibitors |
| 04/28/2004 | CN1492929A Myocyte differentiation factor Fwa 267 |
| 04/28/2004 | CN1492928A Cell proliferation factor Fwap 10576 |
| 04/28/2004 | CN1492873A Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 04/28/2004 | CN1492868A Quinuclidine carbamate derivatives and their use as m3 antigonists |
| 04/28/2004 | CN1492860A 喹唑啉衍生物 Quinazoline derivatives |
| 04/28/2004 | CN1492762A Azoles as malonyl-COA decarboxylase inhibitors useful as metabolic modulators |
| 04/28/2004 | CN1492759A Device and method for preventing or treating failure of hemodialysis vascular access and other vascular grafts |
| 04/28/2004 | CN1492737A Functional agent for decomposing nicotine and method of preparing the same |
| 04/28/2004 | CN1492735A Non invasive measurements of chemical substances |
| 04/28/2004 | CN1491950A Extracting process for bilobalide A, B, C and its preparation |
| 04/28/2004 | CN1491942A Non humidity suction stable crystalline form of N-[N-N-(4-piperidine-4-yl)-N-ethyl glycyl) compound |
| 04/28/2004 | CN1491722A Compound alliin powder injection |
| 04/28/2004 | CN1491720A Inducer of blood vessel neogenesis |
| 04/28/2004 | CN1491715A Chewing tablet of fleece-flower root and preparing method |
| 04/28/2004 | CN1491707A Pulse-activating astragalus root soft capsule and its preparing method |
| 04/28/2004 | CN1491706A Soft capsule for removing blood stasis in chest and its preparing method |
| 04/28/2004 | CN1491705A Oral preparation for cerebral embolism and its preparing method |
| 04/28/2004 | CN1491704A Chinese herbal medicine for treating cardio-cerebral vascular disease and health care and its preparing method |
| 04/28/2004 | CN1491690A Process for preparing Chinese medicine soft capsule for treating and preventing thrombotic obliterating disease |
| 04/28/2004 | CN1491689A Process for preparing Chinese medicinal dripping pills for treating and preventing ischemic cardio-cerebral vascular diseases |
| 04/28/2004 | CN1491683A Chinese medicine adhesive film for preventing and treating coronary heart disease and angina pectoris and its preparing method |
| 04/28/2004 | CN1491682A Recovery capsule for infarct |
| 04/28/2004 | CN1491663A Oral administration preparation of total red peoniforin and its preparing method |
| 04/28/2004 | CN1491662A Injection of total red penoniforin and its preparing method |
| 04/28/2004 | CN1491659A Notoginseng total saponin powder injection and preparing process |
| 04/28/2004 | CN1491658A Notiginseng total saponin liposome and its preparation |
| 04/28/2004 | CN1491642A Adhesive film agent and its preparing method |
| 04/28/2004 | CN1147505C G-protein receptor HTNAD 29 |
| 04/28/2004 | CN1147495C Alkyl-4-silylheterocyclic phenols and thiophenols as antioxidant agents |
| 04/28/2004 | CN1147492C New metal protease inhibitors its preparing method and their medicinal composition containing them |
| 04/28/2004 | CN1147489C New bicyclo aminopyrazineone compound, its production process and medical composition containing them |
| 04/28/2004 | CN1147482C Substittued (dihydro) benzoxazole and (dihydro)benzoxazine compound and its preparation and medicine composite |
| 04/28/2004 | CN1147476C Pyrazole derivatives as P-38 MAP kinase inhibitors |
| 04/28/2004 | CN1147471C Renin inhibitors |
| 04/28/2004 | CN1147470C Novel 2,3,3A,4,9,9A hexahydro-8-hydroxy-1H-benz[f] indoles, a method for the production thereof, and their use as medicine |
| 04/28/2004 | CN1147461C 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof |
| 04/28/2004 | CN1147459C Galcium receptor-active compound |
| 04/28/2004 | CN1147309C Medicine for treatnig heart disease and promoting recovery |
| 04/28/2004 | CN1147300C Vitronectin receptor antagonist |
| 04/28/2004 | CN1147299C Indole-3-propionic acids, salts and esters thereof used as medicaments |
| 04/28/2004 | CN1147296C Preparation method of medicine for resisting ischemic and brain trauma using taurine |
| 04/28/2004 | CA2447199A1 Homing of embryonic stem cells to a target zone in tissue using active therapeutics or substances |
| 04/28/2004 | CA2447190A1 Homing of donor cells to a target zone in tissue using active therapeutics or substances |
| 04/28/2004 | CA2447167A1 Homing of autologous cells to a target zone in tissue using active therapeutics or substances |
| 04/27/2004 | US6727364 Antiinflammatory agents |
| 04/27/2004 | US6727352 Methods of making macrolides |
| 04/27/2004 | US6727279 Central nervous system disorders |
| 04/27/2004 | US6727275 Pyrrolidinone derivatives |
| 04/27/2004 | US6727269 Acromegaly, pituitary adenoma or endocrine gastroenteropanceatic tumors including the carcinoid syndrome, and gastrointestinal bleeding |
| 04/27/2004 | US6727266 Substituted tryptophan derivatives |
| 04/27/2004 | US6727261 Pyrido[2,1-A]Isoquinoline derivatives |
| 04/27/2004 | US6727260 Using compounds capable of inhibiting the activity of a proton-gated cation channel in therapy or aleviation of diseases or disorders associated with, or mediated by a drop in extracellular ph |
| 04/27/2004 | US6727258 Allosteric adenosine receptor modulators |
| 04/27/2004 | US6727256 4-aminoquinazoline derivatives as anticarcinogenic agents |
| 04/27/2004 | US6727255 Brain, nervous system and psychological disorders |
| 04/27/2004 | US6727253 Use of a topo ii catalytic nhibitor such as the bisdioxopiperazine icrf-187, a quinoline, aclarubicin, and an acridine. |
| 04/27/2004 | US6727251 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 04/27/2004 | US6727247 Adenosine receptor ligands in a method of treatment, control, or prevention of central nervous system disorders |